Solazyme Appoints Jean-Marc Rotsaert as Chief Operating Officer
Former President and CEO of AAK USA brings commercial oils industry and sales
experience to rapidly growing renewable oil company
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2012
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2012 /PRNewswire/ --Solazyme, Inc.
(NASDAQ: SZYM), a renewable oil and bioproducts company, announced today that
Jean-Marc Rotsaert has joined the company as its Chief Operating Officer. As
COO, Mr. Rotsaert will be responsible for leading Solazyme's operations,
including the continued expansion of the tailored oils sales and marketing
organization with a focus on the industrial and nutritional markets.
"Jean-Marc is a proven leader who has a deep understanding of the
international and domestic triglyceride oils market. His impressive track
record of success in leading businesses through rapid growth is ideally suited
for Solazyme at a time when we are scaling our commercial operations," said
Jonathan Wolfson, CEO, Solazyme. "Jean-Marc brings a rare combination of
industry sales, marketing and technology experience in both industrial and
nutritional markets. This skill set will positively contribute to Solazyme,
delivering profitable and sustainable growth."
"Solazyme is in a rapid growth phase and I am excited to join the team in
commercializing this ground breaking technology that will change the oil
paradigm. As the company builds out production capacity to meet market demand
for its tailored oils technology, I look forward to growing the commercial and
sales infrastructure and to helping achieve Solazyme's mission to provide new
healthy, sustainable oils to the industry and to the world," said Mr.
Mr. Rotsaert joins Solazyme from AAK where he was the President and CEO of the
U.S. business. AAK is a leading global provider of specialty vegetable oils
and fats to many industries. The profits of the U.S. business more than
quadrupled over his tenure in the midst of the global financial crisis. Prior
to his work with AAK, Mr. Rotsaert was Vice President of Science and
Technology at Campbell's Soup. Before that, he was Vice President of Research
and Development at Pepsico International (UK and Ireland) where he was a main
operating board member accountable for the management of a $2 billion business
unit. In addition, he was functionally accountable for new product
development, product quality, productivity, product and consumer insights
(market research team and analytical laboratories), regulatory compliance, and
consumer services and nutrition across multiple food brands of the Pepsico
portfolio. Before his time at Pepsico, Mr. Rotsaert was a Managing
Director/Program Manager at The Coca-Cola Company where he transformed an R&D
group from cost to profit center in the U.S.
About Solazyme, Inc.
Solazyme, Inc. (NASDAQ: SZYM) is a renewable oil and bioproducts company that
transforms a range of low-cost plant-based sugars into high-value oils.
Headquartered in South San Francisco, Solazyme's renewable products can
replace or enhance oils derived from the world's three existing sources –
petroleum, plants and animal fats. Initially, Solazyme is focused on
commercializing its products into three target markets: (1) fuels and
chemicals, (2) nutrition and (3) skin and personal care.
Solazyme®, the Solazyme logo and other trademarks or service names are
trademarks of Solazyme, Inc.
This press release contains certain forward-looking statements about Solazyme,
including statements that involve risks and uncertainties concerning: its
commercialization plans; its build-out of capacity; the anticipated demand for
its products; the attributes of its products and its ability to deliver
profitable and sustainable growth. When used in this press release, the words
"will", "expects", "intends" and other similar expressions and any other
statements that are not historical facts are intended to identify those
assertions as forward-looking statements. Any such statement may be
influenced by a variety of factors, many of which are beyond the control of
Solazyme, that could cause actual outcomes and results to be materially
different from those projected, described, expressed or implied in this press
release due to a number of risks and uncertainties. Potential risks and
uncertainties include, among others: implementation risk in deploying new
technologies; Solazyme's limited history in commercializing products; market
acceptance of its products; its limited experience in constructing and
operating commercial manufacturing facilities; its ability to obtain requisite
regulatory approvals; its ability to enter into and maintain strategic
collaborations; and its access, on favorable terms, to any required financing.
Accordingly, no assurances can be given that any of the events anticipated by
the forward-looking statements will transpire or occur, or if any of them do
so, what impact they will have on the results of operations or financial
condition of Solazyme.
In addition, please refer to the documents that Solazyme files with the
Securities and Exchange Commission, including its Quarterly Reports on Form
10-Q, for a discussion of these and other risks. You are cautioned not to
place undue reliance on forward-looking statements, which speak only as of the
date of this press release. Solazyme is not under any duty to update any of
the information in this press release.
SOURCE Solazyme, Inc.
Contact: For Media Inquiries: Genet Garamendi, Vice President, Corporate
Communications, 650-963-5228, Press@solazyme.com, or For Investor Inquiries:,
Jeff Majtyka, firstname.lastname@example.org, Brad Edwards, Edwards@braincomm.com,
Press spacebar to pause and continue. Press esc to stop.